NCT01700946 Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma Status COMPLETED Phase PHASE2
NCT01697527 Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01697293 PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01696877 A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01690520 Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes Status COMPLETED Phase PHASE2
NCT01689987 Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT01681563 Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT01679119 Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy Status COMPLETED Phase PHASE2
NCT01679041 High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Treatment Status TERMINATED Phase PHASE2
NCT01677949 Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia Status WITHDRAWN Phase PHASE2
NCT01670084 Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia Status WITHDRAWN Phase PHASE2
NCT01660750 A Safety Study of Carfilzomib, Cyclophosphamide & Dexamethasone Prior to ASCT in Patients With Newly Diagnosed Myeloma Status COMPLETED Phase PHASE1
NCT01659658 Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis Status TERMINATED Phase PHASE3
NCT01653717 CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL) Status COMPLETED Phase PHASE1
NCT01652092 Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies Status ACTIVE_NOT_RECRUITING Phase NA